Discovery of a New Antibiotic Demethoxytetronasin Using a Dual-Sided Agar Plate Assay (DAPA).
Streptomyces sp
antibiotic bioassay
demethoxytetronasin
dual-sided agar plate assay (DAPA)
tetronasin
Journal
ACS infectious diseases
ISSN: 2373-8227
Titre abrégé: ACS Infect Dis
Pays: United States
ID NLM: 101654580
Informations de publication
Date de publication:
11 08 2023
11 08 2023
Historique:
pmc-release:
14
07
2024
medline:
17
8
2023
pubmed:
14
7
2023
entrez:
14
7
2023
Statut:
ppublish
Résumé
For over a century, researchers have cultured microorganisms together on solid support─typically agar─in order to observe growth inhibition via antibiotic production. These simple bioassays have been critical to both academic researchers that study antibiotic production in microorganisms and to the pharmaceutical industry's global effort to discover drugs. Despite the utility of agar assays to researchers around the globe, several limitations have prevented their widespread adoption in advanced high-throughput compound discovery and dereplication campaigns. To address a list of specific shortcomings, we developed the dual-sided agar plate assay (DAPA), which exists in a 96-well plate format, allows microorganisms to compete through opposing sides of a solid support in individual wells, is amenable to high-throughput screening and automation, is reusable, and is low-cost. Herein, we validate the use of DAPA as a tool for drug discovery and show its utility to discover new antibiotic natural products. From the screening of 217 bacterial isolates on multiple nutrient media against 3 pathogens, 55 hits were observed, 9 known antibiotics were dereplicated directly from agar plugs, and a new antibiotic, demethoxytetronasin (
Identifiants
pubmed: 37450563
doi: 10.1021/acsinfecdis.3c00171
pmc: PMC10426401
doi:
Substances chimiques
Anti-Bacterial Agents
0
Agar
9002-18-0
Biological Products
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1593-1601Subventions
Organisme : FIC NIH HHS
ID : D43 TW010530
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI160696
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM125943
Pays : United States
Références
Appl Environ Microbiol. 1985 Dec;50(6):1357-60
pubmed: 16346938
Nucleic Acids Res. 2022 Jan 7;50(D1):D665-D677
pubmed: 34791429
Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):10124-10129
pubmed: 30228116
Nat Chem Biol. 2019 Feb;15(2):161-168
pubmed: 30617293
J Pharm Anal. 2016 Apr;6(2):71-79
pubmed: 29403965
Planta Med. 2014 Sep;80(14):1182-99
pubmed: 25221978
Elife. 2020 Jun 17;9:
pubmed: 32553109
Nat Biotechnol. 2016 Aug 9;34(8):828-837
pubmed: 27504778
Pharmaceuticals (Basel). 2022 Oct 21;15(10):
pubmed: 36297414
Appl Environ Microbiol. 1988 Feb;54(2):544-7
pubmed: 3355139
J Nat Prod. 2017 Mar 24;80(3):684-691
pubmed: 28128950
Appl Environ Microbiol. 1988 Dec;54(12):2981-5
pubmed: 3223764
Antonie Van Leeuwenhoek. 2012 Aug;102(2):361-74
pubmed: 22562433
PLoS One. 2021 Nov 5;16(11):e0258934
pubmed: 34739482
J Nat Prod. 2023 Mar 24;86(3):574-581
pubmed: 36881908
FEMS Microbiol Lett. 2005 Aug 15;249(2):211-8
pubmed: 16006057
Nat Prod Rep. 2014 Nov;31(11):1554-84
pubmed: 24965099
Proc Natl Acad Sci U S A. 2018 May 8;115(19):4981-4986
pubmed: 29686101
J Nat Prod. 2019 Aug 23;82(8):2167-2173
pubmed: 31335140
Toxicol In Vitro. 2021 Aug;74:105137
pubmed: 33684466
J Exp Med. 1939 Jun 30;70(1):1-10
pubmed: 19870884
FEMS Microbiol Lett. 2013 Jan;338(2):161-7
pubmed: 23210858
J Am Soc Mass Spectrom. 2004 Mar;15(3):325-35
pubmed: 14998534